Exagen Inc (XGN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access XGN Annual Balance Sheets →
Examining balance sheet movements between Exagen Inc and Jun 30 2025 reveals how Jun 30 2026 adjusts its asset composition and liability profile.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent24.59
Cash & Short-term Investments24.00
Accounts receivable12.41
Other Current Assets0.00
Total loans net5.90
Total Current Assets42.86
Prepaid Expense and Other Assets, Total0.00
Other Assets, Noncurrent9.08
Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization6.61
Operating Lease Right Of Use Asset1.18
Total Assets51.94
Liabilities
Accounts Payable, Current AC4.44
Accrued Liabilities, Current AC4.94
Long-term Debt, Current Maturities LO0.52
Other Liabilities, Current3.56
Total Current Liabilities13.46
Long-term debt22.84
Total Long-term Debt22.84
Other liabilities, Noncurrent3.42
Operating Lease Liability Current1.26
Total Liabilities39.72
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock333.64
Retained Earnings / Accumulated Deficit-321.45
Other Equity0.00
Common Stockholder's Equity12.22
Total Stockholder's Equity12.22
Liabilities & Stockholder's Equity51.94
4 historic quarters locked

Sign in to unlock the full Exagen Inc balance sheet history.

About Exagen Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001274737-26-000048

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.